Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Dominant mutations in superoxide dismutase cause amyotrophic lateral sclerosis (ALS), a progressive paralytic disease characterized by loss of motor neurons. With the use of mice carrying a deletable mutant gene, expression within motor neurons was shown to be a primary determinant of disease onset and of an early phase of disease progression. Diminishing the mutant levels in microglia had little effect on the early disease phase but sharply slowed later disease progression. Onset and progression thus represent distinct disease phases defined by mutant action within different cell types to generate non–cell-autonomous killing of motor neurons; these findings validate therapies, including cell replacement, targeted to the non-neuronal cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“accumulation of mutant SOD1 in microglia may further amplify their proinflammatory and neurotoxic activity (149, 150).”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [150]
Citations
Cites
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Generalized lacZ expression with the ROSA26 Cre reporter strain
Soriano, P. (1999) · Nature Genetics · doi:10.1038/5007 · Cited by 4,859
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus
Srinivas, S., Watanabe, T., Lin, C.-S., William, C. M., Tanabe, Y., Jessell, T. M., & Costantini, F. (2001) · BMC Developmental Biology · doi:10.1186/1471-213x-1-4 · Cited by 3,121
Microglia as a source and target of cytokines
Hanisch, U. (2002) · Glia · doi:10.1002/glia.10161 · Cited by 1,645
Wong, P. C., Pardo, C. A., Borchelt, D. R., Lee, M. K., Copeland, N. G., Jenkins, N. A., Sisodia, S. S., Cleveland, D. W., & Price, D. L. (1995) · Neuron · doi:10.1016/0896-6273(95)90259-7 · Cited by 1,445
Self-citationBruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., Sisodia, S. S., Rothstein, J. D., Borchelt, D. R., Price, D. L., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80272-x · Cited by 1,341
Self-citationUNRAVELING THE MECHANISMS INVOLVED IN MOTOR NEURON DEGENERATION IN ALS
Bruijn, L. I., Miller, T. M., & Cleveland, D. W. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144244 · Cited by 1,185
Self-citationWild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice
Clement, A. M., Nguyen, M. D., Roberts, E. A., Garcia, M. L., Boillée, S., Rule, M., McMahon, A. P., Doucette, W., Siwek, D., Ferrante, R. J., et al. (2003) · Science · doi:10.1126/science.1086071 · Cited by 1,100
Self-citation
Research works printed but not linked: 2
- T. Kawamata, H. Akiyama, T. Yamada, P. L. McGeer, Am. J. Pathol.140, 691 (1992).
- A. Mazzone, G. Ricevuti, Haematologica80, 161 (1995).
Cited by
Items 401–500 of 1,001
Nardo, G., Iennaco, R., Fusi, N., Heath, P. R., Marino, M., Trolese, M. C., Ferraiuolo, L., Lawrence, N. D., Shaw, P. J., & Bendotti, C. (2013) · Brain · doi:10.1093/brain/awt250 · Cited by 102
Kang, J., & Rivest, S. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200705046 · Cited by 94
TRPM7 and TRPM2—Candidate susceptibility genes for Western Pacific ALS and PD?
Hermosura, M. C., & Garruto, R. M. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.02.008 · Cited by 105
Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis
Rizzo, F., Riboldi, G. M., Salani, S., Nizzardo, M., Simone, C., Corti, S. P., & Hedlund, E. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1480-4 · Cited by 106
Thomsen, G. M., Avalos, P., Ma, A. A., Alkaslasi, M., Cho, N., Wyss, L., Vit, J.-P., Godoy, M., Suezaki, P., Shelest, O., et al. (2018) · Stem Cells · doi:10.1002/stem.2825 · Cited by 93
Targeted gene silencing in the nervous system with CRISPR-Cas13
Powell, J. E., Lim, C. K. W., Krishnan, R., McCallister, T. X., Saporito-Magriña, C., Zeballos, M. A., McPheron, G. D., & Gaj, T. (2022) · Science Advances · doi:10.1126/sciadv.abk2485 · Cited by 92
Extracellular vesicles, from the pathogenesis to the therapy of neurodegenerative diseases
Xia, X., Wang, Y., & Zheng, J. C. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00330-0 · Cited by 92
Sunyach, C., Michaud, M., Arnoux, T., Bernard‐Marissal, N., Aebischer, J., Gourdou‐Latyszenok, V., Gouarné, C., Raoul, C., Pruss, R. M., Bordet, T., et al. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.02.013 · Cited by 105
TDP-43-Based Animal Models of Neurodegeneration: New Insights into ALS Pathology and Pathophysiology
Wegorzewska, I., & Baloh, R. H. (2011) · Neurodegenerative Diseases · doi:10.1159/000321547 · Cited by 93
Diseases associated with leaky hemichannels
Retamal, M. A., Reyes, E. P., GarcÃa, I. E., Pinto, B. I., MartÃnez, A. D., & González, C. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00267 · Cited by 93
Plasma biomarkers associated with ALS and their relationship to iron homeostasis
Mitchell, R. M., Simmons, Z., Beard, J. L., Stephens, H., & Connor, J. R. (2010) · Muscle & Nerve · doi:10.1002/mus.21625 · Cited by 97
Forostyak, S., Homola, A., Turnovcova, K., Svitil, P., Jendelova, P., & Sykova, E. (2014) · Stem Cells · doi:10.1002/stem.1812 · Cited by 92
Lepore, A. C., Dejea, C. M., Carmen, J., Rauck, B. M., Kerr, D. A., Sofroniew, M. V., & Maragakis, N. J. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.02.020 · Cited by 104
The spinal cord ependymal region: A stem cell niche in the caudal central nervous system
Hugnot, J. (2010) · Frontiers in bioscience · doi:10.2741/3734 · Cited by 101
Heterozygous Tbk1 loss has opposing effects in early and late stages of ALS in mice
Brenner, D., Sieverding, K., Bruno, C., Lüningschrör, P., Buck, E., Mungwa, S., Fischer, L., Brockmann, S. J., Ulmer, J., Bliederhäuser, C., et al. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20180729 · Cited by 83
Self-citationFeng, X., Peng, Y., Liu, M., & Cui, L. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.10.009 · Cited by 95
Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective
Malaspina, A., Puentes, F., & Amor, S. (2015) · International Immunology · doi:10.1093/intimm/dxu099 · Cited by 91
Importance of Functional Loss of FUS in FTLD/ALS
Ishigaki, S., & Sobue, G. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2018.00044 · Cited by 91
Gibb, S. L., Boston-Howes, W., Lavina, Z. S., Gustincich, S., Brown, R. H., Pasinelli, P., & Trotti, D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704314200 · Cited by 93
Neuroinflammation in motor neuron disease
Endo, F., Komine, O., & Yamanaka, K. (2016) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12309 · Cited by 91
Self-citationGlia in neurodegeneration: Drivers of disease or along for the ride?
Gleichman, A. J., & Carmichael, S. T. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104957 · Cited by 90
Toll-like receptors in central nervous system injury and disease: A focus on the spinal cord
Heiman, A., Pallottie, A., Heary, R. F., & Elkabes, S. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.06.203 · Cited by 98
Glial activation colocalizes with structural abnormalities in amyotrophic lateral sclerosis
Alshikho, M. J., Zürcher, N. R., Loggia, M. L., Cernasov, P., Chonde, D. B., Izquierdo Garcia, D., Yasek, J. E., Akeju, O., Catana, C., Rosen, B. R., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003427 · Cited by 90
MiR-124 and the Underlying Therapeutic Promise of Neurodegenerative Disorders
Han, D., Dong, X., Zheng, D., & Nao, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01555 · Cited by 90
Clonally expanded CD8 T cells characterize amyotrophic lateral sclerosis-4
Campisi, L., Chizari, S., Ho, J., Gromova, A., Arnold, F. J., Mosca, L., Mei, X., Fstkchyan, Y. S., Torre, D., Beharry, C., et al. (2022) · Nature · doi:10.1038/s41586-022-04844-5 · Cited by 99
Yanpallewar, S. U., Barrick, C. A., Buckley, H., Becker, J., & Tessarollo, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039946 · Cited by 90
Park, S., Kim, H.-T., Yun, S., Kim, I., Lee, J., Lee, I.-S., & Park, K. I. (2009) · Experimental & Molecular Medicine · doi:10.3858/emm.2009.41.7.054 · Cited by 94
Martorana, F., Brambilla, L., Valori, C. F., Bergamaschi, C., Roncoroni, C., Aronica, E., Volterra, A., Bezzi, P., & Rossi, D. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr513 · Cited by 90
Watanabe, S., Ageta-Ishihara, N., Nagatsu, S., Takao, K., Komine, O., Endo, F., Miyakawa, T., Misawa, H., Takahashi, R., Kinoshita, M., et al. (2014) · Molecular Brain · doi:10.1186/s13041-014-0062-1 · Cited by 90
Self-citationNeuroprotection: Targeting Multiple Pathways by Naturally Occurring Phytochemicals
Khan, A., Jahan, S., Imtiyaz, Z., Alshahrani, S., Makeen, H. A., Alshehri, B., Kumar, A., Arafah, A. M., & Rehman, M. U. (2020) · Biomedicines · doi:10.3390/biomedicines8080284 · Cited by 100
Abnormal Changes in NKT Cells, the IGF-1 Axis, and Liver Pathology in an Animal Model of ALS
Finkelstein, A., Kunis, G., Seksenyan, A., Ronen, A., Berkutzki, T., Azoulay, D., Koronyo-Hamaoui, M., & Schwartz, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022374 · Cited by 87
Gustafson, M. P., Staff, N. P., Bornschlegl, S., Butler, G. W., Maas, M. L., Kazamel, M., Zubair, A., Gastineau, D. A., Windebank, A. J., & Dietz, A. B. (2017) · PLOS ONE · doi:10.1371/journal.pone.0182002 · Cited by 88
Carra, S., Rusmini, P., Crippa, V., Giorgetti, E., Boncoraglio, A., Cristofani, R., Naujock, M., Meister, M., Minoia, M., Kampinga, H. H., et al. (2013) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0409 · Cited by 88
Liu, W., Venugopal, S., Majid, S., Ahn, I. S., Diamante, G., Hong, J., Yang, X., & Chandler, S. H. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104877 · Cited by 85
Lerman, B. J., Hoffman, E. P., Sutherland, M. L., Bouri, K., Hsu, D. K., Liu, F., Rothstein, J. D., & Knoblach, S. M. (2012) · Brain and Behavior · doi:10.1002/brb3.75 · Cited by 88
Hedlund, E., Karlsson, M., Osborn, T. M., Ludwig, W. W., & Ole Isacson, A. (2010) · Brain · doi:10.1093/brain/awq167 · Cited by 98
The role of CNS glia in preserving axon function
Edgar, J. M., & Nave, K. (2009) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2009.08.003 · Cited by 101
Expression of mutant SOD1G93A in astrocytes induces functional deficits in motoneuron mitochondria
Bilsland, L. G., Nirmalananthan, N., Yip, J., Greensmith, L., & Duchen, M. R. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05699.x · Cited by 88
Fendrick, S. E., Xue, Q.-S., & Streit, W. J. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-9 · Cited by 88
Mitochondrial damage revealed by immunoselection for ALS-linked misfolded SOD1
Pickles, S., Destroismaisons, L., Peyrard, S. L., Cadot, S., Rouleau, G. A., Brown, R. H., Julien, J.-P., Arbour, N., & Vande Velde, C. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt249 · Cited by 88
Svahn, A. J., Don, E. K., Badrock, A. P., Cole, N. J., Graeber, M. B., Yerbury, J. J., Chung, R., & Morsch, M. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1875-2 · Cited by 87
The contribution of the peripheral immune system to neurodegeneration
Berriat, F., Lobsiger, C. S., & Boillée, S. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01323-6 · Cited by 87
Self-citationA Clear and Present Danger: Endogenous Ligands of Toll-like Receptors
Sloane, J. A., Blitz, D., Margolin, Z., & Vartanian, T. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8094-x · Cited by 89
Adult glial precursor proliferation in mutant SOD1G93A mice
Magnus, T., Carmen, J., Deleon, J., Xue, H., Pardo, A. C., Lepore, A. C., Mattson, M. P., Rao, M. S., & Maragakis, N. J. (2008) · Glia · doi:10.1002/glia.20604 · Cited by 87
The interplay between inflammation and neurodegeneration in CNS disease
Esiri, M. M. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.013 · Cited by 90
Neuroinflammation in motor neuron disease.
Komine, O., & Yamanaka, K. (2015) · PubMed · doi:10.18999/nagjms.77.4.537 · Cited by 65
Self-citationThe multifaceted role of glial cells in amyotrophic lateral sclerosis
Valori, C. F., Brambilla, L., Martorana, F., & Rossi, D. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1429-7 · Cited by 100
Ling, S.-C., Dastidar, S. G., Tokunaga, S., Ho, W. Y., Lim, K., Ilieva, H., Parone, P. A., Tyan, S.-H., Tse, T. M., Chang, J.-C., et al. (2019) · eLife · doi:10.7554/elife.40811 · Cited by 86
Self-citationThe neurobiology of amyotrophic lateral sclerosis
Bento‐Abreu, A., Van Damme, P., Van Den Bosch, L., & Robberecht, W. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07260.x · Cited by 85
Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis
Giunti, D., Parodi, B., Cordano, C., Uccelli, A., & Kerlero de Rosbo, N. (2014) · Immunology · doi:10.1111/imm.12177 · Cited by 85
Neurodegenerative diseases: The immunological perspective
Molteni, M., & Rossetti, C. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.11.002 · Cited by 88
CSF sAPPβ, YKL-40, and NfL along the ALS-FTD spectrum
Illán-Gala, I., Alcolea, D., Montal, V., Dols-Icardo, O., Muñoz, L., de Luna, N., Turón-Sans, J., Cortés-Vicente, E., Sánchez-Saudinós, M. B., Subirana, A., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000006383 · Cited by 85
Neurotoxicity by microglia: Mechanisms and potential therapeutic strategy
Takeuchi, H. (2010) · Clinical and Experimental Neuroimmunology · doi:10.1111/j.1759-1961.2009.00001.x · Cited by 85
Taylor, D. M., Gibbs, B. F., Kabashi, E., Minotti, S., Durham, H. D., & Agar, J. N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610119200 · Cited by 85
Tokuda, E., Okawa, E., Watanabe, S., Ono, S.-I., & Marklund, S. L. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.01.001 · Cited by 84
Weisman, G. A., Camden, J. M., Peterson, T. S., Ajit, D., Woods, L. T., & Erb, L. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8263-z · Cited by 100
Neuron-specific antioxidant OXR1 extends survival of a mouse model of amyotrophic lateral sclerosis
Liu, K. X., Edwards, B., Lee, S., Finelli, M. J., Davies, B., Davies, K. E., & Oliver, P. L. (2015) · Brain · doi:10.1093/brain/awv039 · Cited by 85
Trias, E., Beilby, P. R., Kovacs, M., Ibarburu, S., Varela, V., Barreto-Núñez, R., Bradford, S. C., Beckman, J. S., & Barbeito, L. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00042 · Cited by 85
Cunha, C., Santos, C., Gomes, C., Fernandes, A. M. A., Correia, A. M., Sebastião, A. M., Vaz, A. R., & Brites, D. M. T. O. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0631-2 · Cited by 93
Raffaele, S., Boccazzi, M., & Fumagalli, M. (2021) · Cells · doi:10.3390/cells10030565 · Cited by 80
Shi, P., Wei, Y., Zhang, J., Gal, J., & Zhu, H. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100366 · Cited by 83
Epigenetic regulation of neuron‐dependent induction of astroglial synaptic protein GLT1
Yang, Y., Gozen, O., Vidensky, S., Robinson, M. B., & Rothstein, J. D. (2010) · Glia · doi:10.1002/glia.20922 · Cited by 82
Aebischer, J., Cassina, P., Otsmane, B., Moumen, A., Seilhean, D., Meininger, V., Barbeito, L., Pettmann, B., & Raoul, C. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.143 · Cited by 102
Complement activation at the motor end-plates in amyotrophic lateral sclerosis
Bahia El Idrissi, N., Bosch, S., Ramaglia, V., Aronica, E., Baas, F., & Troost, D. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0538-2 · Cited by 81
MicroRNA Profiling Reveals Marker of Motor Neuron Disease in ALS Models
Hoye, M. L., Koval, E. D., Wegener, A. J., Hyman, T. S., Yang, C., O'Brien, D. R., Miller, R. L., Cole, T., Schoch, K. M., Shen, T., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.3582-16.2017 · Cited by 82
Molecular subtypes of ALS are associated with differences in patient prognosis
Eshima, J., O’Connor, S. A., Marschall, E., NYGC ALS Consortium, Bowser, R., Plaisier, C. L., & Smith, B. S. (2023) · Nature Communications · doi:10.1038/s41467-022-35494-w · Cited by 79
The heat shock response in neurons and astroglia and its role in neurodegenerative diseases
San Gil, R., Ooi, L., Yerbury, J. J., & Ecroyd, H. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0208-6 · Cited by 81
Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders
Anderson, K. M., Olson, K. E., Estes, K. A., Flanagan, K., Gendelman, H. E., & Mosley, R. L. (2014) · Translational Neurodegeneration · doi:10.1186/2047-9158-3-25 · Cited by 81
Yu, M., Zhou, H., Zhao, J., Xiao, N., Roychowdhury, S., Schmitt, D., Hu, B., Ransohoff, R. M., Harding, C. V., Hise, A. G., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131314 · Cited by 81
Modeling cell-autonomous motor neuron phenotypes in ALS using iPSCs
Hawrot, J., Imhof, S., & Wainger, B. J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104680 · Cited by 74
Neymotin, A., Petri, S., Calingasan, N. Y., Wille, E., Schafer, P., Stewart, C., Hensley, K., Beal, M. F., & Kiaei, M. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.08.028 · Cited by 80
Selective targeting of microglia by quantum dots
Minami, S. S., Sun, B., Popat, K., Kauppinen, T., Pleiss, M., Zhou, Y., Ward, M. E., Floreancig, P., Mucke, L., Desai, T., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-22 · Cited by 80
PGC-1 is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosis
Eschbach, J., Schwalenstocker, B., Soyal, S. M., Bayer, H., Wiesner, D., Akimoto, C., Nilsson, A.-C., Birve, A., Meyer, T., Dupuis, L., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt202 · Cited by 75
Silencing strategies for therapy of SOD1-mediated ALS
van Zundert, B., & Brown, R. H. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.07.059 · Cited by 84
Role and Therapeutic Potential of Astrocytes in Amyotrophic Lateral Sclerosis
Pehar, M., Harlan, B. A., Killoy, K. M., & Vargas, M. R. (2018) · Current Pharmaceutical Design · doi:10.2174/1381612823666170622095802 · Cited by 78
Spreading of amyotrophic lateral sclerosis lesions--multifocal hits and local propagation?
SEKIGUCHI, T., Kanouchi, T., Shibuya, K., Noto, Y., Yagi, Y., Inaba, A., Abe, K., Misawa, S., Orimo, S., Kobayashi, T., et al. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305617 · Cited by 84
Witan, H., Kern, A., Koziollek-Drechsler, I., Wade, R., Behl, C., & Clement, A. M. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn025 · Cited by 78
Casanovas, A., Hernández, S., Tarabal, O., Rosselló, J., & Esquerda, J. E. (2008) · Journal of Comparative Neurology · doi:10.1002/cne.21527 · Cited by 78
Mandrioli, J., Amedei, A., Cammarota, G., Niccolai, E., Zucchi, E., D'Amico, R., Ricci, F., Quaranta, G., Spanu, T., & Masucci, L. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01021 · Cited by 78
Therapeutic neuroprotective agents for amyotrophic lateral sclerosis
Pandya, R. S., Zhu, H., Li, W., Bowser, R. P., Friedlander, R. M., & Wang, X. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1415-0 · Cited by 90
Noh, M., Kwon, H. S., Kwon, M., Nahm, M., Jin, H. K., Bae, J., & Kim, S. H. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00867-4 · Cited by 97
Ayers, J. I., Fromholt, S., Sinyavskaya, O., Siemienski, Z., Rosario, A. M., Li, A., Crosby, K. W., Cruz, P. E., DiNunno, N. M., Janus, C., et al. (2015) · Molecular Therapy · doi:10.1038/mt.2014.180 · Cited by 76
Höing, S., Rudhard, Y., Reinhardt, P., Glatza, M., Stehling, M., Wu, G., Peiker, C., Böcker, A., Parga, J. A., Bunk, E. C., et al. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.07.005 · Cited by 84
Amyotrophic lateral sclerosis: all roads lead to Rome
Aguilar, J. G. D., Echaniz‐Laguna, A., Fergani, A., René, F., Meininger, V., Loeffler, J., & Dupuis, L. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04408.x · Cited by 77
ALS: astrocytes move in as deadly neighbors
Julien, J. (2007) · Nature Neuroscience · doi:10.1038/nn0507-535 · Cited by 79
Roser, A.-E., Tönges, L., & Lingor, P. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00094 · Cited by 77
The Global Economic Impact of Neurodegenerative Diseases: Opportunities and Challenges
Zahra, W., Nand, S., Birla, H., Singh, S. S., Dilnashin, H., Rathore, A. S., & Singh, S. P. (2019) · Springer eBooks · doi:10.1007/978-981-13-9431-7_17 · Cited by 113
Charcot–Marie–Tooth disease and intracellular traffic
Bucci, C., Bakke, O., & Progida, C. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.03.003 · Cited by 83
CSF glial markers correlate with survival in amyotrophic lateral sclerosis
Süssmuth, S. D., Sperfeld, A. D., Hinz, A., Brettschneider, J., Endruhn, S., Ludolph, A. C., & Tumani, H. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d5dc3b · Cited by 76
Gerber, Y. N., Sabourin, J.-C., Rabano, M., Vivanco, M. D. M., & Perrin, F. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036000 · Cited by 76
Microglia can be induced by IFN-γ or IL-4 to express neural or dendritic-like markers
Butovsky, O., Bukshpan, S., Kunis, G., Jung, S., & Schwartz, M. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.04.009 · Cited by 90
van der Graaff, M. M., de Jong, J. M. B. V., Baas, F., & de Visser, M. (2008) · Neuromuscular Disorders · doi:10.1016/j.nmd.2008.10.002 · Cited by 85
Yaron, A., & Schuldiner, O. (2016) · Current Biology · doi:10.1016/j.cub.2016.05.025 · Cited by 76
Exploring the genetics and non-cell autonomous mechanisms underlying ALS/FTLD
Chen, H., Kankel, M. W., Su, S. C., Han, S., & Ofengeim, D. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0060-4 · Cited by 78
Glial Cells—The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment
Filipi, T., Heřmanová, Z., Turečková, J., Vaňátko, O., & Anděrová, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010261 · Cited by 80
Comley, L., Allodi, I., Nichterwitz, S., Nizzardo, M., Simone, C., Corti, S., & Hedlund, E. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.02.013 · Cited by 75
Hayworth, C. R., & Gonzalez-Lima, F. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.08.031 · Cited by 74
Comley, L. H., Nijssen, J., Frost‐Nylen, J., & Hedlund, E. (2015) · The Journal of Comparative Neurology · doi:10.1002/cne.23917 · Cited by 79
Romer, S. H., Seedle, K., Turner, S. M., Li, J., Baccei, M. L., & Crone, S. A. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.05.033 · Cited by 74
Autophagy and Neurodegeneration: Insights from a Cultured Cell Model of ALS
Navone, F., Genevini, P., & Borgese, N. (2015) · Cells · doi:10.3390/cells4030354 · Cited by 74
Metadata
- Authors
- Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W.
- Affiliations
- Ludwig Institute for Cancer Research and Departments of Medicine and Neuroscience, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.
- University of California San Diego (US)
- ORCID
- Venue
- Science
- Published
- 2006-06-02
- Volume
- 312
- Issue
- 5778
- Pages
- 1389-1392
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2033158384
- Cited by
- 1,623
- References
- 28
- Citations by year
- 2026: 42 · 2025: 40 · 2024: 52 · 2023: 59 · 2022: 69 · 2021: 60 · 2020: 95 · 2019: 82 · 2018: 74 · 2017: 84 · 2016: 82 · 2015: 81 · 2014: 109 · 2013: 107 · 2012: 115
- FWCI
- 66.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS 27036, R37NS027036)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- amyotrophic lateral sclerosis, motor neurons, microglia, disease onset, disease progression, cell replacement therapy, mouse model
- MeSH terms
- Superoxide Dismutase-1, Amyotrophic Lateral Sclerosis, Animals, Female, Humans, Male, Mice, Inbred C57BL, Mice, Transgenic, Motor Neurons, Mutation, Superoxide Dismutase, Microglia, Disease Progression, Integrases, CD11b Antigen, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.